
2.83 Delayed Data As of Dec 04 | ![]() Today’s Change | 1.30 Today|||52-Week Range 8.15 | -44.62% Year-to-Date |
The 4 analysts offering 12-month price forecasts for Checkpoint Therapeutics Inc have a median target of 21.00, with a high estimate of 47.00 and a low estimate of 8.00. The median estimate represents a +642.05% increase from the last price of 2.83.
The current consensus among 4 polled investment analysts is to Buy stock in Checkpoint Therapeutics Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.